Pseudoephedrine alternatives
This article was originally published in The Tan Sheet
Executive Summary
Store-brand phenylephrine products from Leiner will begin shipping in June to fill the gap on retail shelves left by pseudoephedrine, the private labeler announced April 22. The announcement follows Target's decision to place pseudoephedrine behind pharmacy counters. Phenylephrine is an active ingredient in Bayer's Alka-Seltzer Plus and compared to pseudoephedrine, "has fewer side effects and...does not interfere with sleep," Leiner claims. The firm's products will compete with Pfizer's Sudafed PE phenylephrine, launched in January, and other private-label offerings...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.